MENU
+Compare
STVN
Stock ticker: NYSE
AS OF
Sep 3 closing price
Price
$23.30
Change
+$0.65 (+2.87%)
Capitalization
6.36B

STVN stock forecast, quote, news & analysis

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries... Show more

STVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. STVN showed earnings on August 05, 2025. You can read more about the earnings report here.
Interact to see
Advertisement
A.I.Advisor
a Summary for STVN with price predictions
Sep 03, 2025

STVN sees its Stochastic Oscillator ascends from oversold territory

On August 20, 2025, the Stochastic Oscillator for STVN moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 43 instances where the indicator left the oversold zone. In of the 43 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 27, 2025. You may want to consider a long position or call options on STVN as a result. In of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for STVN just turned positive on August 28, 2025. Looking at past instances where STVN's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where STVN advanced for three days, in of 267 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 104 cases where STVN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

STVN moved below its 50-day moving average on August 05, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for STVN crossed bearishly below the 50-day moving average on August 11, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where STVN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

STVN broke above its upper Bollinger Band on August 28, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. STVN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.883) is normal, around the industry mean (10.879). P/E Ratio (40.590) is within average values for comparable stocks, (58.911). STVN's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.712). Dividend Yield (0.003) settles around the average of (0.016) among similar stocks. P/S Ratio (4.739) is also within normal values, averaging (38.309).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STVN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Intuitive Surgical (NASDAQ:ISRG), Align Technology (NASDAQ:ALGN).

Industry description

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

Market Cap

The average market capitalization across the Pharmaceuticals: Other Industry is 10.78B. The market cap for tickers in the group ranges from 246 to 158.15B. ISRG holds the highest valuation in this group at 158.15B. The lowest valued company is PEMTF at 246.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Other Industry was -2%. For the same Industry, the average monthly price growth was 7%, and the average quarterly price growth was 34%. TUTH experienced the highest price growth at 52%, while YBGJ experienced the biggest fall at -53%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Other Industry was -27%. For the same stocks of the Industry, the average monthly volume growth was -34% and the average quarterly volume growth was -17%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 65
Price Growth Rating: 60
SMR Rating: 80
Profit Risk Rating: 91
Seasonality Score: -29 (-100 ... +100)
View a ticker or compare two or three
STVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
Via Molinella 17
Phone
+39 49931811
Employees
5635
Web
https://www.stevanatogroup.com